Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
Curr Opin Organ Transplant. 2021 Jun 1;26(3):309-313. doi: 10.1097/MOT.0000000000000873.
The use of procedural mechanical support during lung transplantation (LTx) varies between centers and the optimal support strategy is still controversially discussed. The two main questions are if cardiopulmonary bypass (CPB) or extracorporeal membrane oxygenation (ECMO) should be preferred and whether mechanical support should be reserved for specific patient groups or a routine use can be recommended.
Recent cohort studies have consistently shown that LTx on CPB leads to inferior outcomes when compared to venoarterial (va)-ECMO. Thus, ECMO should be preferred in lung transplantation except for special indications. Despite its higher invasiveness, ECMO offers some pivotal advantages over off-pump lung transplantation. It has been shown to remarkably reduce rates of primary graft dysfunction, supporting the concept of a routine intraoperative ECMO use in LTx.
Although randomized-controlled trials addressing this question are still lacking, current evidence appears to favor the routine use of ECMO support during lung transplantation.
肺移植(LTx)过程中程序性机械支持的使用因中心而异,而最佳支持策略仍存在争议。两个主要问题是心肺旁路(CPB)或体外膜氧合(ECMO)应优先选择,以及机械支持是否应保留用于特定患者群体或可推荐常规使用。
最近的队列研究一致表明,与静脉动脉(va)-ECMO 相比,CPB 上的 LTx 导致预后不良。因此,除非有特殊指征,否则 ECMO 应优先用于肺移植。尽管 ECMO 具有更高的侵袭性,但与非体外循环肺移植相比,它具有一些关键优势。它已被证明可显著降低原发性移植物功能障碍的发生率,支持在 LTx 中常规术中使用 ECMO 的概念。
尽管仍缺乏针对此问题的随机对照试验,但现有证据似乎倾向于常规使用 ECMO 支持进行肺移植。